Construction and application of saccharomyces cerevisiae genetically engineered bacteria for producing heme by adopting fermentation method
The invention discloses construction and application of saccharomyces cerevisiae genetically engineered bacteria for producing heme by adopting a fermentation method. The invention provides Saccharomyces cerevisiae TIB H1, and the preservation registration number of the Saccharomyces cerevisiae TIB...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses construction and application of saccharomyces cerevisiae genetically engineered bacteria for producing heme by adopting a fermentation method. The invention provides Saccharomyces cerevisiae TIB H1, and the preservation registration number of the Saccharomyces cerevisiae TIB H1 is CGMCC (China General Microbiological Culture Collection Center) No. 21000. The invention also protects the application of the saccharomyces cerevisiae TIB H1 in the production of heme. The invention also protects a method for producing the heme. The method comprises the following steps: fermenting and culturing the saccharomyces cerevisiae TIB H1. A certain foundation is laid for efficient production of the heme by the saccharomyces cerevisiae, and the method has industrial value for industrial production of the heme.
本发明公开了发酵法生产血红素的酿酒酵母基因工程菌的构建与应用。本发明提供了酿酒酵母(Saccharomyces cerevisiae)TIB H1,保藏登记号为CGMCC No.21000。本发明还保护酿酒酵母TIB H1在生产血红素中的应用。本发明还保护一种生产血红素的方法,包括如下步骤:发酵培养酿酒酵母TIB H1。本发明为酿酒酵母高效生产血红素奠定了一定基础,对于血红素的工业生产 |
---|